Abstract
We have previously shown that all-trans retinoic acid (ATRA) increases the number of CFU-GM colonies grown from unseparated human bone marrow cells with crude sources of colony stimulating factors. In this study, we further characterized the effect of ATRA on the growth of CFU-GM stimulated by individual cytokines from multiple samples of CD34+enriched or purified human bone marrow cells. The number of IL-3- or GM-CSF-induced CFU-GM with 3 × 10−7M ATRA was 3.25 ± 1.13, and 2.17 ± 0.8-fold greater respectively, compared to controls without ATRA, while G-CSF had no effect and the ratio of colony-induced with or without ATRA was 1.06 ± 0.17 (P = 0.00012). No colonies grew with ATRA + IL-6 or ATRA without a cytokine. Maximum enhancing effect on IL-3-induced CFU-GM occurred when ATRA was added on day 2, gradually diminished when delaying ATRA, and in cultures of day 9 or older adding ATRA had no effect. In 14 days liquid cultures of purified CD34+ cells with IL-3, ATRA increased the number of myeloid differentiated cells to 91–95%, compared to 37–70% with IL-3 alone. In addition, the number of apoptotic cells using the annexin V method increased after 14 days from 5.1% with IL-3 to 17.1% with IL-3 + ATRA and by the TUNEL in situ method from 10–26% to 60–95%, respectively. This study demonstrates that ATRA consistently enhances the growth of myeloid progenitors from CD34+ cells. This effect is dependent on the stimulating cytokine, suggesting the myeloid cells responding to ATRA are the less mature CFU-GMs that are targets of IL-3 and GM-CSF and not the G-CSF-responding mature progenitors. The growth stimulation by ATRA and IL-3 is also associated with granulocyte differentiation and increased apoptosis. These studies further suggest a potential role of pharmacological doses of ATRA on the development of normal human hematopoietic cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout



Similar content being viewed by others
References
Hoffman C, Eichele G . Retinoids in development. In: Sporn MB, Roberts AB, Goodman DS (eds) The Retinoids: Biology, Chemistry and Medicine, 2nd edn Raven Press: New York 1994 387–442
Smith MA, Parkinson DR, Cheson B, Friedman MA . Retinoids in cancer therapy J Clin Oncol 1992 10: 839–864
Means AL, Gudas LJ . The role of retinoids in vertebrate development Annu Rev Biochem 1995 64: 201–233
Goodman DW . Vitamin A and retinoids in health and disease New Engl J Med 1984 310: 1023–1034
Breitman TR, Selonik SE, Collins SJ . Induction of differentiation of human progranulocytic leukemia cell line (HL-60) by retinoic acid Proc Natl Acad Sci USA 1980 77: 2936–2940
Tsai S, Collins SJ . A dominant negative retinoic acid receptor blocks neutrophil differentiation at the promyelocytic stage Proc Natl Acad Sci USA 1993 90: 7153–7157
de The H, Marchio A, Tiollais P, Dejean A . Differential expression and ligand regulation of the retinoic acid receptor alpha and beta genes EMBO J 1989 8: 429–443
Largman C, Detmer K, Corral JC, Hack FM, Lawrence HJ . Expression of retinoic acid receptor alpha mRNA in human leukemia cells Blood 1989 74: 99–102
Breitman TR, Collins SJ, Keene BR . Terminal differentiation of human promyelocytic leukemic cells in primary culture in response to retinoic acid Blood 1981 57: 1000–1004
Chomienne C, Ballerini P, Balitrand N, Daniel MT, Fenaux P, Castaigne, Degos L . All trans retinoic acid in acute promyelocytic leukemia. II. In vitro studies: structure–function relationship Blood 1990 76: 1710–1717
Warrel RP Jr, de The H, Want Z-Y, Degos L . Acute promyelocytic leukemia New Engl J Med 1993 329: 177–189
Elliott S, Taylor K, White S, Rodwell R, Marlton P, Meagher D, Wiley J, Taylor D, Wright S, Timms P . Proof of differentiative mode of action of all-trans retinoic acid in acute promyelocytic leukemia using X-linked clonal analysis Blood 1992 79: 1916–1919
Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Fausner JH, Ogden A, Sheperd L, Bloomfiled CJ, Head DR, Weinstein HJ, Woods WG, Rowe JM, Weirnick PA . A prospective randomized trial of all-trans-retinoic acid in induction and maintenance therapy for patients with acute promyelocytic leukemia New Engl J Med 1997 337: 1021–1028
Fenaux P, Le Delay MC, Castaigne S, Archibaud E, Chemoienne C, Link H, Guerci A, Duarte M, Daniel MT, Bowen D, Huebner G, Bauters F, Fegueux DN, Fey M, Sanz B, Lowenberg B, Maloisel F, Auzanneau G, Sadoum A, Gardia C, Bastion Y, Gasner A, Jacky E, Dombert H, Chastang C, Degos L, and the European APL 91 Group . Effect of all-trans retinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial Blood 1993 82: 3241–3249
de The H, Chomienne H, Lannotte M, Degos L, Dejean A . The t(15;17) translocation of acute promyelocytic leukemia fuses the retinoic acid receptor α gene to a novel transcribed locus Nature 1990 347: 358–361
Kakizuka A, Miller WH, Umesono K, Warrell RP, Frankel SR, Murty VVVS, Dmitrovsky E, Evans RM . Chromosomal translocation t(15;17) of human acute promyelocytic leukemia fuses RAR alpha gene with a novel putative transcription factor, PML Cell 1991 66: 663–674
Pandolfi PP, Grignani F, Alcalay M, Mencarelli A, Biondi A, Lo Coco F, Grignani F, Pelicci PG . Structure and origin of the acute promyelocytic leukemia myl/RAR-α cDNA and characterization of its retinoid-binding and transactivation properties Oncogene 1991 6: 1285–1292
Grignani F, Fagioli M, Alcalay M, Longo L, Pandolfi PP, Donti E, Biondi A, LoCoco F, Grignani F, Pelicci PG . Acute promyelocytic leukemia: from genetics to treatment Blood 1994 83: 10–25
Grignani FR, Ferruci PF, Testa U, Talamo G, Fagioli M, Alcalay M, Mencarelli A, Grignani F, Peschle C, Nicoletti I, Pelicci PG . The acute promyelocytic leukemia specific PML/RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells Cell 1993 74: 423–431
Mernick A, Licht JD . Deconstructing a disease: RARα, its fusion partners and their roles in the pathogenesis of acute promyelocytic leukemia Blood 1999 93: 3167–3215
Dermine S, Grignani F, Clerici M, Nervi C, Sozi G, Talamo GP, Marchesi E, Formelli F, Parmiani G, Pelicci PG, Gambacorti-Passerini C . Occurrence of resistance to retinoic acid in the acute promyelocytic leukemia cell line NB4 is associated with altered expression of the PML/RARα protein Blood 1993 82: 1573–1577
Degos L, Dombret H, Chomienne C, Daniel MT, Miclea JM, Chastang C, Castaigne S, Fenaux P . All-trans retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia Blood 1995 85: 2643–2653
Douer D, Koeffler HP . Retinoic acid enhances colony stimulating factor-induced clonal growth of normal human myeloid progenitor cells in vitro Exp Cell Res 1982 138: 193–198
Nagler A, Riklis I, Kletter Y, Tatarsky I, Fabian I . Effect of 1, 2-dihydroxy vitamin D3 and retinoic acid on normal human pluripotent (CFU-mix) erythroid (BFU-E) and myeloid (CFU-C) progenitor cell growth and differentiation patterns Exp Hematol 1986 14: 60–65
Aglietta M, Piacibello W, Stacchini A, Sanavio F, Gavosto F . In vitro effect of retinoic acid on normal and chronic myeloid leukemia granulopoiesis Leukemia Res 1985 9: 879–885
Gratas C, Menot ML, Dresch C, Chomienne C . Retinoic acid supports granulocytic but not erythroid differentiation of myeloid progenitors in normal bone marrow cells Leukemia 1993 7: 1156–1162
Tobler A, Dawson MI, Koeffler HP . Retinoids: structure–function relationship in normal and leukemic hematopoiesis in vitro J Clin Invest 1986 78: 303–309
Labbaye C, Voltier M, Testa U Gaimpaolo A, Meccia E, Sterpetti P, Parolini I, Pelosi E, Bulgarini D, Cayre YE, Peschle C . Retinoic acid down modulates erythroid differentiation and GATA-1 expression in purified adult progenitor cultures Blood 1994 83: 651–656
Zauli G, Visani G, Vitale M, Gibellini D, Bertolaso L, Capitani S . All-trans retinoic acid shows multiple effects on the survival proliferation and differentiation on human fetal CD34+ hematopoietic progenitor cells Br J Haematol 1995 90: 274–282
Tocci A, Parolini I, Gabbianelli M, Testa U, Luchetti L, Samoggia P, Masella B, Russo G, Valtieri M, Peschle C . Dual action of retinoic acid on human embryonic/fetal hematopoiesis: blockade of primitive progenitor proliferation and shift from multipotent/erythroid/monocytic to granulocytic differentiation program Blood 1996 88: 2878–2888
van Bockstaele DR, Lenjou M, Snoeck HW, Lardon F, Stryckmans P, Peetermans ME . Direct effects of 13-cis and all-trans retinoic acid on normal bone marrow (BM) progenitors: comparative study on BM mononuclear cells and on isolated CD34+ BM cells Ann Hematol 1993 66: 61–66
Ormerod MG, Collins MKL, Rodriguez-Tarduchy G, Robertson D . Apoptosis in interleukin-3-dependent hematopoietic cells. Quantification by two flow cytometric methods J Immunol Meth 1992 153: 57–67
Sach L . The control of hematopoiesis and leukemia from basic biology to the clinic Proc Natl Acad Sci USA 1996 93: 4742–4751
Koopman G, Reutelingsperger CPM, Kuitjen GAM, Keehnen RMJ, Pals ST, van Oers MHJ . Annexin V for flow cytometric detection of phosphatidylserine expression of B cells undergoing apoptosis Blood 1994 84: 1415–1422
Gorczyca W, Gong J, Darzynkiewiczj A . Detection of DNA stand breaks in individual apoptotic cells by the in situ terminal deoxynucleatidyl transferase and nick translation assay Cancer Res 1993 53: 1945–1953
Tohda S, Minden MD, McCullock EA . Interaction between retinoic acid and colony stimulation factor affecting the blast cells of acute myeloblastic leukemia Leukemia 1991 5: 951–957
Smeland EB, Rusten L, Jacobsen SEW, Skrede B, Blomhoff R, Wang MY, Funderud S, Kvalheim G, Blomhoff HK . All-trans retinoic acid directly inhibits granulocyte colony-stimulating factor-induced proliferation of CD34+ human hematopoietic progenitor cells Blood 1994 84: 2940–2945
Emerson SG, Yang YC, Clark SC, Long MW . Human recombinant granulocyte–macrophage colony stimulating factor and interleukin 3 have overlapping but distinct hematopoietic activities J Clin Invest 1988 82: 1282–1287
Caux C, Saeland S, Favre C, Duvert V, Mannoni P, Banchereau J . Tumor necrosis factor-alpha strongly potentiates interleukin-3 and granulocyte–macrophage colony-stimulating factor-induced proliferation of human CD34+ hematopoietic progenitor cells Blood 1990 75: 2292–2298
Josefsen D, Blomhoff HK, Lomo J, Blystad AK, Smeland EB . Retinoic acid induces apoptosis of human CD34(+) hematopoietic progenitors: involvement of retinoic acid receptors and retinoid X receptors depends on lineage commitment of the hematopoietic progenitor cells Exp Hematol 1999 27: 642–653
Ninomiya Y, Adams R, Morris-Kay GM, Eto K . Apoptotic cell death in neuronal differentiation of P19 EC cells: cell death follows reentry into S phase J Cell Physiol 1997 175: 25–35
Evans G, Harrington E, Fanidi A, Land H, Amati B, Bennett M . Integrated control of cell proliferation and cell death by the c-myc oncogene Phil Trans Royal Soc Long B Biol Sci 1994 345: 269–275
Lotem J, Sachs L . Coupling of growth and differentiation in normal myeloid precursors and the breakdown of this coupling in leukemia Int J Cancer 1983 32: 127–134
Metcalf D . The molecular control of cell division, differentiation commitment and maturation in hematopoietic cells Nature 1989 339: 27–35
Lee EY, Hu N, Yuan SS, Cox LA, Bradley A, Lee WH, Herrup K . Dual role of the retinoblastoma protein in cell cycle regulation and neuron differentiation Gene Dev 1994 8: 2008–2021
Okazawa H, Shimizu J, Imafuku I, Hamada H . Bcl-2 inhibits retinoic acid-induced apoptosis during the neural differentiation of embryonal stem cells J Cell Biol 1996 132: 955–968
Martin SJ, Bradley JG, Cotter TG . HL-60 cells induced to differentiate towards neutrophils subsequently die via apoptosis Clin Exp Immunol 1990 79: 448–453
Park JR, Robertson K, Hickstein DD, Tsai S, Hockenbery DM, Collins SJ . Dysregulated bcl-2 expression inhibits apoptosis but not differentiation of retinoic acid-induced HL-60 granulocytes Blood 1994 84: 440–445
Lee JS, Newman RA, Lippman SM, Hubner MH, Minor T, Raber MN, Krakoff IH, Hong WK . Phase I evaluation of all-trans retinoic acid in adults with solid tumors J Clin Oncol 1993 11: 959–966
Kahn MC, Luginbuhl W, Gaines L, Bratschi J . Leukocytosis associated with all-trans-retinoic acid therapy in metastatic non-small-cell lung cancer J Natl Cancer Inst 1992 84: 1669–1670
Frankel SR, Earldley A, Lauwers G, Weiss M, Warrel R . The ‘retinoic acid syndrome’ in acute promyelocytic leukemia Ann Intern Med 1992 117: 292–296
Acknowledgements
This work was supported in large part by the USC/Norris Comprehensive Cancer Center NCI Core Grant 5P30CA14089. The authors thank Gus Miranda and Brandy Chong for their excellent secretarial support in preparing this manuscript and Mark Heckinger for his assistance with the flow cytometry assays.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Douer, D., Ramezani, L., Parker, J. et al. All-trans-retinoic acid effects the growth, differentiation and apoptosis of normal human myeloid progenitors derived from purified CD34+ bone marrow cells. Leukemia 14, 874–881 (2000). https://doi.org/10.1038/sj.leu.2401772
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.leu.2401772
Keywords
This article is cited by
-
The role of retinoids and retinoic acid receptors in normal hematopoiesis
Leukemia (2002)
-
Signaling revisited in acute promyelocytic leukemia
Leukemia (2002)
-
Orchestration of multiple arrays of signal cross-talk and combinatorial interactions for maturation and cell death: another vision of t(15;17) preleukemic blast and APL-cell maturation
Oncogene (2001)
-
Enhanced ability of daniplestim and myelopoietin-1 to suppress apoptosis in human hematopoietic cells
Leukemia (2001)


